[Purpose] We attempted to induce differentiation into various organs by forming embryoid bodies from the hwnan amniotic stem cells (HAM-I) and mouse EES cells (early embryonic stem cells). [Materials and Methods] One hundred cells each mixed anEGFP gene induction human amnion origin stem cell line (HAM-I EGFP) and a ddYmouse EES-7 cells were cultured inthehanging drop condition fortwo days and formed theembryoid bodies. TheculnJre medium used wasaMEM supplemented with 1()O!O FBS and embryotrophic factor!(ETFs). Furthermore, The embryoid bodies were cultured at stationary condition in thesame medium. [Results andConclusion] Theembryoid bodies grew and formed theprimordial organs of a trilaminar germ disc origin (blood island, skin, digestive orgaJH1)i1he1iurn, alveoral , blood vessel, blood cell). Fluorescence was recognized inthese primordial orpns were recognized by.AHAM-I cell suggests that itisstem cell having multipotency differentiating toprimordial organs of trilaminar genndisc origin. Regenerative medicine, in particular that using somatic (tissue) stem ceJJs, has received a considerable amount of attention in recent years, and in the field of periodontics, bone regeneration has been a major obstacle for some time. In this study, we attempted to induce differentiation of tissue stem ceJJs in the periodontal ligament into osteoblasts. The placenta is an integral part of embryogenesis, and since odontogenesis occurs at weeks 7-10 of gestation in humans, we speculated that physiologicaJJy active substances that induce odontogenesis must be present in the early placenta during this time. Therefore, with patient consent, the early placenta (week 8 of gestation) was cultured in a DMEMlFl2 medium (10% FBS) as follows: the placenta was washed, perfused, cut into small pieces and then dissociated in 0.2% trypsin-O.02% EDTAlPBS(-) for primary culture. After confirming ceJJular proliferation, a conditioned medium was collected after three days of serum-free culturing, lyophilized and dialyzed to prepare placental embryotrophic factors (P-ETF). In addition, with patient consent, the periodontal ligament was collected during tooth extraction in orthodontic treatment. The periodontal ligament was minced and treated with the above-mentioned digestive enzyme solution for primary culture. The above-mentioned P-ETF was added to the cultured periodontal ligament cells for up to five generations to induce differentiation into osteoblasts. Osteoblasts were identified by anti-osteonectin, anti-osteopontin, anti-osteocalcin immunostaining and electron microscope. The results showed that P-ETF induced differentiation into osteoblasts in a dose-dependent manner, clarifying that tissue stem cells or the progenitor cells of osteoblasts are present in the cells that make up the periodontal ligament. Since P-ETF contains several growth factors and cytokines, we are planning to investigate which of these compounds or unidentified compounds induce differentiation. -vitro over considerable period oftime (over three month), and succeeded in establishing cell lines. In the early period of the primary culture, the astrocytoma cells were characteristics of contacting each other by their cytoplasmic processes and the oligodendroglioma cells were small spindle-shaped cells and were characterized as posessing the cytoplasmic processes, the glioblastoma cells revearled neoplastic and pleopmorphic features and were characterized as posessing the cytoplasmic pmcesses, the ependpoma cells were characterized as f m i n g the rosset-like cell anangemenf meningioma cells were! spindle-or round-shaped cells and characterized as forming psammoma bodies, pituhy adenoma cells were! round-or oval-shaped cells and producing GH, ACTH, prolactin, etc. the neurinoma cells were spindle-or fitxousshaped cells, and the m a l i w t lymphoma cells were round and formed cell aggregates floating in the culture medium. In our knowledge, itisthefirst report thatthe cell line secreting P1lI, P1HrP andAcrn wassuccessfully established. We expect thatOS-I contribute to study on the mechanism ofectopic hormone secretion.
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Abstract
The cell line designed JHUCS-l was established from a carcinosarcoma (malignant mixed mesodermal tumor) of the uterus that was surgically removed from a 57-year-old Japanese woman. She underwenta hysterectomy, bilateral salpingo-oophorectomy, omentectomy and splenectomyfor the uterine malignancy on October 18, 1998. She had received neither chemotherapy nor radiation therapy before surgery.The pathologic diagnosis was a carcinosarcoma (stage IVb, pTl bNOM 1) and a metastatic sarcoma that was observed in the spleen. We carefully examined the histopathology of the original tumor after the cell line was established and noted differentiation into a neuroendocrine carcinoma within the tumor's epithelial components. Immunohistochemical staining of the tumorous tissue that had been heterotransplanted was positive for Leu7. Additionally, secretary granules were observed in the grafted cells as determined by electron microscopy. These results support the existence of neuroendocrine cells within the JHUCS-I cell line. Since few reports have been published describing the establishment of cell lines in long-term culture of human uterine carcinosarcomas, and none have documented neuroendocrine differentiation, the JHUCS-l cell line we established will be used for future basic research studies on this tumor. (Materials andMethods] The carcinoma cell was obtained from 60years oldJapanese woman. After obtaining patient consent theascitic fluid wasremoved fiomtheabdominal cavity andwasused forcellculture. Tumor cellwereisolated bycentrifugation (1000 rpm5 minutes) from theascitic fluid. The ceUs were dispersed Ham'sFI2 medium supplemented with 15%offetalcalf serum, andincubated at 37"C muter 5% C~in air. HYKSSPC wasmaintained over24 months, and successfully subcultured over33times; therefore we designated this cell line.
(results] The population doubling timeofHYKSSPC was51.4hours. A phase contract micrograph of HYKSSPC showsthepavement stonelikearrangement without contact inJubition. The chromosome number showed a wide distnbution of aneuploid. Unfortunately the cells were could not xenotransplanted into thenudemice.
(conclusion] SSPC wasfirst descnbed as mesothelioma resembling papillaJy ovarian adenocarinoma bySwerdlow in 1959. Nevertheless, themechanisms of itsprogress has notyet beencleared justenough. So webelieve finnIy that this cell linewill be amost useful material in investigation oftheunusual disease. Thiscelllinehasbeenpreserving somecharacters ofthe adenocarcinoma withgrowth in vitro.
P-4-06 A novel ceO linederivedfrom a human smau ceO lung carcinomathat secretes There arefewcasereports describing small celllung carcinomas (SC1£), which secrete PTII-related protein (PTII-rP) andresuh inhypercalcemia. Wehave established a novel cellline, derived fiom37-year old women withSCLC, thatproduced PTII-rP, and proopiomelanocortin (POMC), and ledto hypercalcemia.
The cellline, so called S1£-1, wasgrown as floting cellcluster inDMEMIF12medium supplemented with I()Diu FBSandhad a population doubling timeof72 hours. The modal chromosome number was47 (98%); marker chromosomes were notobserved. TheSLC-I cell line secreted notonlyPTII-rP butalso PTH,and bothwere decreased byCaCI 2 administration. Decreasing the concentration ofCa++ inthegrowthmedium stimulated the secretion ofboth PllI-rP andPllI. Since PTII-rP and PTII secretion fiom the SLC-I ceUs was related to Ca++ concentration inthegrowth medium, thecell linemight be useful forthestudyofPTIl-rP and PTII regulation as well as for SC1£ analysis.
On theother hand,theceUs secreted N terminal POMC, theprecursor ofACIH, which wasstimulated by CRH.
E1ecIron micrographs revealed thattherewere two kinds of cells. However, it hasnot beenknown a single cellsecretes PTII, PTII-rPandPOMCsimultaneously or not In summary, weestablished a novel celllineS1£-I , which derived SC1£, thatproduced PTII-rp, PTIIand POMC.
P4-07 Natural killer-ceU and natural killer-like T-cellleukemia-lymphoma cell lines: Immunoprofiling and transcription factorexpression NKT-cell line. NK activity was heterogeneous among thecelllines. CD158A, CD158B, CD159and CD212 werefound to bespecific forNK-cell lines. AllNK-cell lines showed positivity forCD2,CD7,C056, CD94, cyCD178 and HLA-DR. However, expression of other antigens washeterogeneous.
Expression profiles ofTFs werealsoanalyzed at mRNA and protein levels inparallel with immunoprofiling, morphological andfunctional analyses. Thefollowing 13 TFs AMLI, CEBPA, E2A, ETS I, GATAI, GATA2,GATA3,IKAROS, IRFI, PAXS, PUI, TBETand rcn wereanalyzed, AMLI, E2A, ETSI, IKAROS and lRFl were found to be positive forallcelllines whereas GATA1turned outto be universally negative. CEBPA, PAX5 and PU1were negative forall cell lines exceptinthree BCP-celliines.
GATA2 was positive for3/5T-cell lines but negative fortheothercelllines. GATA3 was positive for7n NK-, 4/5NKT-, 5/5T-and 213 BCP-celliines. Most strikingly, TBETwas positive forallNK-andNKT-cell lines and negative forallT-and BCP-celliines. In contrast to theexpression ofTBET, TCF1wasnegative forallNK-and NKT-cell lines, beingpositive for4/5T-and 113 BCP-celliines. Expression analysis ofTFs revealed thatNK-andNKT-cell lines showed identical profiles, clearly distinct from thoseof theT-ALLor BCP-ALL leukemia-derived cell lines. The composite dataon these NK-andNKT-cell lines allow forthe operational defmition oftypical neoplastic NK-and NKT-cell line profiles. NK-andNKT-cell leukemiallymphoma cell lineswill prove invaluable models forstudies of normal and malignant NK-and NKT-cell biology. Chemotherapy, an established agent or cocktail regimen, is usually chosen in relation to the pathogenesis of the cancer. We often experience dissimilar effect and receptivity rates of anticancer agents in different individuals with the same diagnosed histology. When conventional susceptibility tests are performed, a cell line from a surgically obtained specimen is established and an anticancer agent is selected through the MTT method etc., a susceptibility test that measures damaged cells. This method at times is known to takes time and is not always a realistic procedure. Especially, susceptibility test against metabolic anticancer drugs such as 5-FU has been very difficult and unreliable.
obtained from surgical specimens were used. Samples were from colon cancer, gastric cancer, hepatocellular carcinoma, cholangiocarcinoma, and pancreatic carcinoma. The sensitivity difference between chemotherapeutic agent in each cell line was observed with and without 5-FU. Disposable oxygen electrode sensor and multi-channel dissolved oxygen meter(D0X 10/96) was use to measure sensitivity. In all 7 cell lines 5-FU alone showed no susceptibility. When 5-FU was added prior, some of the agents such as MMC , ADM , CPA , VP-I 6 , CPT-I 1 , and ACNU the individual samples demonstrated a positive change in susceptibility. The susceptibility test using the multi-channel dissolved oxygen meter can accurately measure multiple samples simultaneously and detect individuality of the neoplasm. Focusing on cell respiration as an indicator of cell metabolism and activity, this made it possible to measure susceptibility to chemotherapeutic agents faster, easier, and more economical than conventional methods. The novel susceptibility device was able to measure difference in susceptibility with metabolic drugs such as 5-FU and the influence to other agents in combination. The cell line, socalled ANA31 0, was grown in DMEM/FI2 medium supplemented with 10010 FBS.A population doubling timeof42 hours at21 passages. The karyotype analysis showshyperdiploid, and model number is 72.The cell secreted HGF( 125 nglml/3 days) inconditioned medium. butdidnot secreted thyroglobulin, thyroxin, and thyrocalcitonin, which was secreted from differentiated thyroid carcinoma.
HGFhasbeen known that it isnotonly hepatic growth factor butisangiogenic factor. Anaplastic carcinoma ishighly malignant, rapidly invading adjacent structures andmetastasizing throughout thebody. And alsoit hasbeen known HGFstimulates otherangiogenic factor, such as VEGF. It might be caused byHGF secretion from anaplastic thyroid carcinoma, that metastasis occurs very frequently, andthegrowth isvery fast than differentiated thyroid carcinoma, In summary, we established a novel cell1ine, which derived from the most aggressive and invasive neoplasm ofthyroid, anaplastic thyroid carcinoma, ANA31 O. Thisis the first report of anaplastic thyroid carcinoma, producing HGF.
